Clinical Trials Browser

Phase 2 × Lymphoma, B-Cell, Marginal Zone × Prednisolone × Clear all

NCT01068392 2014-11-04

Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)

Phase 2 Completed

Recurrence, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone